Genetic Markers in Lung Cancer Diagnosis: A Review

Clinical implications of intratumor heterogeneity: challenges and opportunities

(2020) Santiago Ramón y Cajal et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages

(2020) Florian Janke et al.   Cancers

Deciphering the Molecular Profile of Lung Cancer: New Strategies for the Early Detection and Prognostic Stratification

(2019) Elisa Dama et al.   Journal of Clinical Medicine

Molecular genetic testing methodologies in hematopoietic diseases: current and future methods

(2019) Kaushik Sridhar et al.   International Journal of Laboratory Hematology

Restriction enzymes and their use in molecular biology: An overview

(2019) Francesca Di Felice et al.   JOURNAL OF BIOSCIENCES

Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?

(2019) Fiorella Calabrese et al.   Journal of Clinical Medicine

Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea

(2019) Kangkook Lee et al.   Cancer Research and Treatment

Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation

(2019) Maria Gabriela O. Fernandes et al.   Cancers

Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

(2019) P. Garrido et al.   Clinical & Translational Oncology

Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective

(2019) D. G. Bebb et al.   Current Oncology

Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?

(2019) Zhichao Liu et al.   TRENDS IN GENETICS

Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing

(2019) Eunhyang Park et al.   Cancer Research and Treatment

Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas

(2019) Jacob M. Sands et al.   LUNG CANCER

Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer

(2018) C Ricordel et al.   ANNALS OF ONCOLOGY

Next-Generation Sequencing Approach to Non–Small Cell Lung Carcinoma Yields More Actionable Alterations

(2018) Mitra Mehrad et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

(2018) Neal I. Lindeman et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Liquid biopsy and its role in an advanced clinical trial for lung cancer

(2018) Donald J Johann et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Performance verification of a plasma-based PD-L1 test that reliably measures mRNA expression from patients with NCSLC.

(2018) Hestia S. Mellert et al.   JOURNAL OF CLINICAL ONCOLOGY

Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer

(2018) Shaohua Lu et al.   LUNG CANCER

Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing

(2018) Qing Zhong et al.   PATHOLOGY RESEARCH AND PRACTICE

Quantitative assessment of gene promoter methylation in non‑small cell lung cancer using methylation‑sensitive high‑resolution melting

(2018) Fangming Liu et al.   Oncology Letters

Principles of Genetic Counseling in the Era of Next-Generation Sequencing

(2018) Mina Yang et al.   Annals of Laboratory Medicine

Liquid biopsy for lung cancer early detection

(2018) Mariacarmela Santarpia et al.   Journal of Thoracic Disease

Diagnosing Lung Cancer: The Complexities of Obtaining a Tissue Diagnosis in the Era of Minimally Invasive and Personalised Medicine

(2018) Anna McLean et al.   Journal of Clinical Medicine

Chemistry-driven Epigenetic Investigation of Histone and DNA Modifications

(2018) Takuma Sueoka et al.   CHEMICAL RECORD

Tumor Mutation Burden as a Biomarker in Resected Non–Small-Cell Lung Cancer

(2018) Siddhartha Devarakonda et al.   JOURNAL OF CLINICAL ONCOLOGY

Serum levels of candidate microRNA diagnostic markers differ among the stages of non‑small‑cell lung cancer

(2018) Toshiko Aiso et al.   Oncology Letters

The role of plasma miRNAs in the diagnosis of pulmonary nodules

(2018) Ke-Xing Xi et al.   Journal of Thoracic Disease

Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC

(2017) Kai Chen et al.   Journal of Thoracic Oncology

Lung cancer: current therapies and new targeted treatments

(2017) Fred R Hirsch et al.   LANCET

Emergence of novel and dominant acquired EGFR solvent-front mutations at Gly796 (G796S/R) together with C797S/R and L792F/H mutations in one EGFR (L858R/T790M) NSCLC patient who progressed on osimertinib

(2017) Sai-Hong Ignatius Ou et al.   LUNG CANCER

Single-cell epigenomics: Recording the past and predicting the future

(2017) Gavin Kelsey et al.   SCIENCE

Lung cancer epigenetics: From knowledge to applications

(2017) Michaël Duruisseaux et al.   SEMINARS IN CANCER BIOLOGY

Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection

(2017) Maria Sromek et al.   CELLULAR ONCOLOGY

High-throughput detection of clinically targetable alterations using next-generation sequencing

(2017) Julie A. Vendrell et al.   Oncotarget

High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer

(2017) Xiaoxiao Xu et al.   Cancer Medicine

Smoking and Lung Cancer: A Geo-Regional Perspective

(2017) Zahraa Rahal et al.   Frontiers in Oncology

Clinical Significance of the KRAS Mutation

(2017) Sead Beganovic   Bosnian Journal of Basic Medical Sciences

Preneoplasia of lung cancer

(2017) Adi F. Gazdar et al.   Cancer Biomarkers

Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society

(2016) Lynette M. Sholl et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Early Events in the Molecular Pathogenesis of Lung Cancer

(2016) H. Kadara et al.   Cancer Prevention Research

Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway

(2016) Yasminka Jakubek et al.   CANCER RESEARCH

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer

(2016) J. F. Gainor et al.   Cancer Discovery

Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis

(2016) Tao Huang et al.   PLoS One

Microarrays – new possibilities for detecting biological factors hazardous for humans and animals, and for use in environmental protection

(2015) Tomasz Mirski et al.   ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

(2015) Lynette M. Sholl et al.   Journal of Thoracic Oncology

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

(2014) Mark G. Kris et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Molecular sputum analysis for the diagnosis of lung cancer

(2013) A J Hubers et al.   BRITISH JOURNAL OF CANCER

Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance

(2013) M Dietel et al.   CANCER GENE THERAPY

Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer

(2013) Soyeon Kim et al.   Journal of Thoracic Oncology

Liquid biopsy: monitoring cancer-genetics in the blood

(2013) Emily Crowley et al.   Nature Reviews Clinical Oncology

Biomarkers and Molecular Testing for Early Detection, Diagnosis, and Therapeutic Prediction of Lung Cancer

(2013) Harvey I. Pass et al.   Thoracic Surgery Clinics

Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification

(2012) William D. Travis et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

The State of Molecular Biomarkers for the Early Detection of Lung Cancer

(2012) M. Hassanein et al.   Cancer Prevention Research

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

Correction: Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer

(2012) Patrick T. Hennessey et al.   PLoS One

A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer

(2011) Fabrizio Bianchi et al.   EMBO Molecular Medicine

Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer

(2011) Niels H.H. Heegaard et al.   INTERNATIONAL JOURNAL OF CANCER

Subtyping of Non-small Cell Lung Carcinoma: A Comparison of Small Biopsy and Cytology Specimens

(2011) Carlie S. Sigel et al.   Journal of Thoracic Oncology

Genomics and the Continuum of Cancer Care

(2011) Ultan McDermott et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

(2010) Lei Yu et al.   INTERNATIONAL JOURNAL OF CANCER

Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers

(2010) Lingxiao Xing et al.   MODERN PATHOLOGY

Diverse somatic mutation patterns and pathway alterations in human cancers

(2010) Zhengyan Kan et al.   NATURE

The landscape of somatic copy-number alteration across human cancers

(2010) Rameen Beroukhim et al.   NATURE

The cancer genome

(2009) Michael R. Stratton et al.   NATURE

TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use

(2009) M. Olivier et al.   Cold Spring Harbor Perspectives in Biology